| View |
2023-01-13-0020
|
HUMAN NORMAL IMMUNOGLOBULIN
|
IMMUNOREL
|
BRP-052
|
ID05F22007
|
Packaging Lot (Box and Vial): ID05F22007
|
30-Sep-25
|
19 January 2023
|
| View |
2023-03-28-0108
|
TETANUS TOXOID
|
BIO-TT
|
BR-663
|
282522
|
Packaging Lot (Box and Ampoule): 0282522
|
30-Sep-25
|
31 March 2023
|
| View |
2023-07-18-0232
|
LIVE ATTENUATED MEASLES, MUMPS AND RUBELLA VACCINE
|
-
|
BR-911
|
0163W004
|
Packaging Lot (Box and Vial): 0163W004; (Diluent): 0681S1340; 0681S1341; 0681S1342
|
30-Sep-25
|
21 July 2023
|
| View |
2023-07-18-0233
|
LIVE ATTENUATED MEASLES, MUMPS AND RUBELLA VACCINE
|
-
|
BR-911
|
0163W005
|
Packaging Lot (Box and Vial): 0163W005; (Diluent): 0681S1340; 0681S1341; 0681S1342
|
30-Sep-25
|
21 July 2023
|
| View |
2023-07-18-0234
|
LIVE ATTENUATED MEASLES, MUMPS AND RUBELLA VACCINE
|
-
|
BR-911
|
0163W006
|
Packaging Lot (Box and Vial): 0163W006; (Diluent): 0681S1340; 0681S1341; 0681S1342
|
30-Sep-25
|
21 July 2023
|
| View |
2023-07-27-0256
|
HEPATITIS B VACCINE (rDNA)
|
-
|
BR-568
|
0352L009
|
Packaging Lot (Box and Vial): 0352L009
|
30-Sep-25
|
01 August 2023
|
| View |
LRV2024-02-06-0046
|
POLIOMYELITIS VACCINE (TYPE 1, 2 AND 3) (INACTIVATED)
|
IMOVAX POLIO
|
BR-929
|
W3H75
|
Packaging Lot (Box): W3H751V; (Vial): W3H75
|
30-Sep-25
|
13 February 2024
|
| View |
LRV2024-03-21-0107
|
ROTAVIRUS VACCINE, LIVE
|
ROTATEQ
|
BR-615
|
1714396
|
Packaging Lot (Box and Tube): Y003122
|
30-Sep-25
|
27 March 2024
|
| View |
LRV2024-04-02-0118
|
RESPIRATORY SYNCYTIAL VIRUS VACCINE (RECOMBINANT, ADJUVANTED)
|
AREXVY
|
BR-1455
|
9M4L3 (ARSEA040C + AAEA06A)
|
Packaging Lot (Box, Vial [Antigen] and Vial [Adjuvant]): 9M4L3
|
30-Sep-25
|
11 April 2024
|
| View |
LRV2024-05-07-0190
|
MEASLES, MUMPS, RUBELLA (MMR) VACCINE (LIVE, ATTENUATED)
|
PRIORIX
|
BR-415
|
A69CF694A
|
Packaging Lot (Box): A69CF694A; (Vial): A69FF694A; (Diluent): A69DF694A; (Needle 25G x 5/8"): 2210017
|
30-Sep-25
|
14 May 2024
|
| View |
LRV2024-01-02-0003
|
HUMAN NORMAL IMMUNOGLOBULIN
|
IMMUNOREL
|
BRP-052
|
ID05G23051
|
Packaging Lot (Box and Vial): ID05G23051
|
30-Sep-26
|
05 January 2024
|
| View |
LRV2024-03-14-0085
|
HUMAN NORMAL IMMUNOGLOBULIN
|
Ig VENA
|
BR-651
|
237503
|
Packaging Lot (Box and Vial): 237503
|
30-Sep-26
|
20 March 2024
|
| View |
LRV2024-04-05-0121
|
PURIFIED VERO CELL RABIES VACCINE
|
ABHAYRAB
|
BR-629
|
23URAB087
|
Packaging Lot (Box and Vial): 23URAB087; (Diluent): SCSVBA1023; (Syringe): 3221357
|
30-Sep-26
|
12 April 2024
|
| View |
LRV2024-04-29-0161
|
TETANUS TOXOID (ADSORBED)
|
T-VAC
|
BR-326
|
2593Q008C
|
Packaging Lot (Box and Ampoule): 2593Q008C
|
30-Sep-26
|
07 May 2024
|
| View |
LRV2024-07-02-0277
|
INACTIVATED PURIFIED RABIES VACCINE (VERO CELL)
|
INDIRAB
|
BR-658
|
62C23056A
|
Packaging Lot (Box and Vial): 62C23056A; (Diluent [Ampoule]): 62F23007A; Syringe with Needle 25G x 1"): 5234J81
|
30-Sep-26
|
05 July 2024
|
| View |
LRV2024-09-06-0410
|
DIPHTHERIA, TETANUS, ACELLULAR PERTUSSIS, INACTIVATED POLIOMYELITIS AND HAEMOPHILUS INFLUENZAE TYPE B CONJUGATE VACCINE, ADSORBED
|
INFANRIX-IPV+HIB
|
BR-659
|
A20CB726A
|
Packaging Lot (Box): A20CB726A; (Vial): A20FB726A; (PFS): A20CB726A/A20LB726A; (Needle 25G X 1"): 2309012
|
30-Sep-26
|
13-Sep-24
|
| View |
LRV2024-10-18-0469
|
DIPHTHERIA, TETANUS, ACELLULAR PERTUSSIS, INACTIVATED POLIOMYELITIS AND HAEMOPHILUS INFLUENZAE TYPE B CONJUGATE VACCINE, ADSORBED
|
INFANRIX - IPV+Hib
|
BR-659
|
A20CB727
|
Packaging Lot (Box): A20CB727A; (Pre-filled Syringe): A20LB727A; (Vial): A20FB727A; (Needle 25G x 1"): 2309012
|
30-Sep-26
|
29 October 2024
|
| View |
LRV2024-11-08-0482
|
RABIES VACCINE (INACTIVATED) (WISTAR STRAIN RABIES)
|
VERORAB
|
BR-220
|
X1C40
|
Packaging Lot (Box): X1C401V; (Vial): X1C40; (Pre-filled Syringe): X3J86
|
30-Sep-26
|
14 November 2024
|
| View |
LRV2024-12-20-0539
|
ANTI-RABIES SERUM (EQUINE)
|
EQUIRAB
|
BR-676
|
A06824029
|
Packaging Lot (Box and Vial): A06824029
|
30-Sep-26
|
26 December 2024
|
| View |
LRV2024-12-23-0540
|
ANTI-RABIES SERUM (EQUINE)
|
EQUIRAB
|
BR-676
|
A06824034
|
Packaging Lot (Box and Vial): A06824034
|
30-Sep-26
|
26 December 2024
|